Disrupting the Future of Pest Control

MXRX Nasdaq ticker reserved

December 09, 2025

*together with Med-x Inc.

Disrupting the Future of Pest Control

Thousands of investors are backing Med-X ahead of its planned Nasdaq listing (ticker: MXRX).

The company's momentum is undeniable ā€“ and the next stage of growth could belong to early shareholders.

For decades, chemical giants have dominated pest control. But the world is changing fast. Governments are banning toxic formulations, consumers demand transparency, and entire industries are being forced to evolve.

Med-X is leading that transition with Nature-Cide, its line of professional-grade, plant-based pesticides designed to perform better ā€“ without the health or environmental risks.

In independent lab studies, Nature-Cide's natural formulations have beaten chemical brands head-to-head, proving that "green" can also mean "powerful."

As the biopesticide market surges 3x by 2030, Med-X is positioned to disrupt a $17 billion industry with U.S.-made, scalable technology that's already trusted worldwide.

Be Part of the Clean Pest Control Revolution.

With $6.4 M in sales, online retail placement through Amazon, Walmart, and Kroger, and expansion into 41 international markets, Med-X is scaling a proven model right as the world shifts toward sustainable agriculture and eco-friendly pest management.

Simpler. Safer. More Effective Pesticides.

Disclosures

This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com  

DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results.

*PAID PROMOTION: We have received two thousand four hundred fifty dollars from IMS for distributing this email to increase public awareness of Med-x Inc. Sherwood Ventures is not responsible for any content hosted on third-party sites or your experience with third-party advertisers. It is the third party's responsibility to ensure compliance with applicable laws. We may hold positions in securities we discuss and may trade without notice. We make no guarantees or warranties about what is advertised and have no fiduciary duty to subscribers. Always consult a qualified financial professional before making investment decisions.